Elvanse 70mg capsules

Elvanse is a prescription medication containing lisdexamfetamine dimesylate, used primarily for the treatment of ADHD. The brand was originally developed by Shire plc, a pharmaceutical company with deep roots in the United Kingdom. Shire was particularly well-known for its focus on neuroscience and rare diseases, bringing this prodrug to market as a therapeutic option for both children and adults.

In 2019, Takeda Pharmaceutical Company Limited, a global biopharmaceutical leader based in Japan, completed a massive acquisition of Shire. This transition brought Elvanse under the Takeda umbrella, integrating it into their global portfolio. While the brand has British origins through Shire, it is now owned and managed by a Japanese conglomerate. Manufacturing typically occurs in specialized pharmaceutical facilities across Multiple countries, including the United States and Europe, to satisfy global demand under strict regulatory oversight.